Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

TNFalpha inhibition in MRL/lpr mice ameliorates pulmonary but not renal disease.

TNFalpha inhibition in MRL/lpr mice ameliorates pulmonary but not renal disease. J Autoimmun. 2002 Dec; 19(4):215-22.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.